105983-77-5

Basic information

• Product Name: METHYL 4-BROMO-3-OXOPENTANOATE
• Synonyms: Pentanoic acid, 4-broMo-3-oxo-, Methyl ester;4-Bromo-3-oxo-pentanoic acid methyl ester
• CAS NO: 105983-77-5
• Molecular Formula: C₆H₉BrO₃
• Molecular Weight: 209.05
• Mol File: 105983-77-5.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 224.12 °C at 760 mmHg
• Flash Point: 89.345 °C
• Appearance: /
• Density: 1.475 g/cm³
• Vapor Pressure: 0.093mmHg at 25°C
• Refractive Index: 1.467
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 9.43±0.50(Predicted)
• CAS DataBase Reference: METHYL 4-BROMO-3-OXOPENTANOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-BROMO-3-OXOPENTANOATE(105983-77-5)
• EPA Substance Registry System: METHYL 4-BROMO-3-OXOPENTANOATE(105983-77-5)

Safety Data

• Hazardous Substances Data: 105983-77-5(Hazardous Substances Data)

Usage

General Description

Methyl 4-bromo-3-oxopentanoate is a chemical compound with the molecular formula C6H9BrO3. It is a bromo derivative of the compound 3-oxopentanoate, which is commonly used in organic synthesis. Methyl 4-bromo-3-oxopentanoate is a versatile intermediate in the production of pharmaceuticals, agrochemicals, and other fine chemicals. It can undergo various chemical reactions such as esterification, hydrolysis, and substitution to produce a wide range of products. Additionally, it is often used as a building block in the synthesis of complex organic molecules.

InChI:InChI=1/C6H9BrO3/c1-4(7)5(8)3-6(9)10-2/h4H,3H2,1-2H3

Upstream product

• 30414-53-0 methyl propanoyl acetate 

Downstream Products

• 175136-29-5 2-[5-methyl-2-phenyl-1,3-thiazol-4-yl]acetic acid methyl ester 
• 477541-27-8 methyl 2-[2-(4-isopropylphenyl)-5-methyloxazol-4-yl]acetate 
• 478541-12-7 2-[5-methyl-2-(6-phenyl-pyridin-3-yl)-thiazol-4-yl]-acetic acid methyl ester 
• 521266-77-3 (2S)-1-({2-[2-(3,5-Dimethoxy-phenyl)-5-methyl-oxazol-4-yl]-ethylamino}-acetyl)-pyrrolidine-2-carbonitrile 
• 521266-79-5 (2S)-1-({2-[2-(4-Fluoro-3-methyl-phenyl)-5-methyl-oxazol-4-yl]-ethylamino}-acetyl)-pyrrolidine-2-carbonitrile 
• 521266-80-8 (2S)-1-({2-[2-(3-Methyl-phenyl)-5-methyl-thiazol-4-yl]-ethylamino}-acetyl)-pyrrolidine-2-carbonitrile 
• 1355450-30-4 methyl {5-methyl-2-[(E)-2-(1-methylcyclohexyl)vinyl]oxazol-4-yl}acetate 
• 1262547-44-3 (S)-3-((S)-2-hydroxy-3-(2-(3-(5-methyl-2-phenyloxazol-4-yl)propyl)benzo[d]oxazol-5-yl)propanoyl)-4-isopropyl oxazolidin-2-one 
• 1262547-43-2 (R)-3-((R)-2-hydroxy-3-(2-(3-(5-methyl-2-phenyloxazol-4-yl)propyl)benzo[d]oxazol-5-yl)propanoyl)-4-isopropyl oxazolidin-2-one 
• 1262547-42-1 (S)-4-isopropyl-3-(3-(2-(3-(5-methyl-2-phenyloxazol-4-yl)propyl)benzo[d]oxazol-5-yl)propanoyl)oxazolidin-2-one 
• 1262547-41-0 (R)-4-isopropyl-3-(3-(2-(3-(5-methyl-2-phenyloxazol-4-yl)propyl)benzo[d]oxazol-5-yl)propanoyl)oxazolidin-2-one 
• 1262547-40-9 3-(2-(3-(5-methyl-2-phenyloxazol-4-yl)propyl)benzo[d]oxazol-5-yl)propanoic acid 
• 1262547-69-2 (S)-2-isopropoxy-3-(2-(3-(5-methyl-2-phenyloxazol-4-yl)propyl)benzo[d]oxazol-5-yl)propanoic acid 
• 1247010-90-7 (S)-2-methoxy-3-(2-(3-(5-methyl-2-phenyloxazol-4-yl)propyl)benzo[d]oxazol-5-yl)propanoic acid 

Relevant articles and documents

METHODS OF TREATING OR PREVENTING COGNITIVE IMPAIRMENT USING INDANE ACETIC ACID DERIVATIVES BASED ON APOE4 GENOTYPE

The present invention provides indane acetic acid and their derivatives and methods for the treating and/or preventing of cognitive disorders based on the ApoE4 genotype of human subjects.

PROCESS FOR THE SYNTHESIS OF A PHOSPHOINOSITIDE 3-KINASE INHIBITOR

The present application is directed to processes and intermediates for making (S)-7-(1-((9H-purin-6-yl)amino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one, which is an inhibitor of phosphoinositide 3-kinases (PI3Ks), useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.

SUBSTITUTED DIAMINO-PYRIMIDINE AND DIAMINO-PYRIDINE DERIVATIVES AS PI3K INHIBITORS

The present invention provides substituted diamino-pyrimidine and substituted diamino-pyridine derivatives of Formula I; wherein X, Y, R1, R2, and Ar are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks